Literature DB >> 8624080

Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease.

U Beffert1, J Poirier.   

Abstract

Apolipoprotein E is a plasma cholesterol and phospholipid transporter which plays a central role in lipoprotein metabolism in the brain. Apolipoprotein E is a polymorphic protein with three common alleles in the general population, designated epsilon 2, epsilon 3 and epsilon 4 coding for proteins ApoE2, ApoE3 and ApoE4, respectively. Recent findings have demonstrated a significant relationship between the epsilon 4 allele and late onset familial and sporadic Alzheimer's disease. We examined several classical neuropathological hallmarks of Alzheimer's disease to determine whether they might be related to apolipoprotein E genotype: the presence of intracellular neurofibrillary tangles, extracellular senile plaques, and the attenuation of choline acetyltransferase activity. Significant correlations were found between epsilon 4 allele copy number and senile plaque density in the frontal, parietal and fusiform cortical areas. Similarly, significant correlations were also found with increased neurofibrillary tangle number in the frontal and fusiform cortex. Interestingly, there was an inverse correlation between the epsilon 4 allele with temporal cortical choline acetyltransferase activity. To further define the specific function of ApoE4, cultured rat hippocampal neurons were used to investigate interactions involving beta-amyloid protein. In this model, ApoE4 (but not ApoE2) was able to reverse the neuroprotective effects of beta-amyloid. ApoE3 was demonstrated to increase the internalization of beta-amyloid peptide into these neurons. Taken together, these results support the involvement of ApoE4 in the pathogenesis of Alzheimer's disease and also provide some explanations for the possible function of this protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624080     DOI: 10.1111/j.1749-6632.1996.tb34415.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  20 in total

1.  APOE ε 4 allele and CSF APOE on cognition in HIV-infected subjects.

Authors:  Marilou A Andres; Ute Feger; Avindra Nath; Sody Munsaka; Caroline S Jiang; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2010-12-24       Impact factor: 4.147

2.  Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity.

Authors:  Shengjun Chang; Tian ran Ma; R Dennis Miranda; Maureen E Balestra; Robert W Mahley; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

Review 3.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Authors:  Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2016-03-08       Impact factor: 13.501

5.  Decreases in plasma A beta 1-40 levels with aging in non-demented elderly with ApoE-epsilon 4 allele.

Authors:  N Pomara; B Shao; T Wisniewski; P D Mehta
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

6.  Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice.

Authors:  Faith M Harris; Walter J Brecht; Qin Xu; Ina Tesseur; Lisa Kekonius; Tony Wyss-Coray; Jo Dee Fish; Eliezer Masliah; Paul C Hopkins; Kimberly Scearce-Levie; Karl H Weisgraber; Lennart Mucke; Robert W Mahley; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-25       Impact factor: 11.205

7.  Apolipoprotein E and traumatic brain injury in a military population: evidence of a neuropsychological compensatory mechanism?

Authors:  S Duke Han; Angela I Drake; Lynne M Cessante; Amy J Jak; Wes S Houston; Dean C Delis; J Vincent Filoteo; Mark W Bondi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-07       Impact factor: 10.154

8.  The relevance of apolipoprotein E polymorphism to Alzheimer's disease.

Authors:  S Narayanan
Journal:  Indian J Clin Biochem       Date:  1999-01

9.  Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.

Authors:  Walter J Brecht; Faith M Harris; Shengjun Chang; Ina Tesseur; Gui-Qiu Yu; Qin Xu; Jo Dee Fish; Tony Wyss-Coray; Manuel Buttini; Lennart Mucke; Robert W Mahley; Yadong Huang
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

10.  APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study.

Authors:  H A D Keage; F E Matthews; A Yip; L Gao; C McCracken; I G McKeith; D C Rubinsztein; C Brayne
Journal:  Age Ageing       Date:  2009-11-24       Impact factor: 10.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.